Concepedia

Claudia M. Espitia

CM

Statistics

Publications

23

Citations

1.4K

H-Index

18

Active since

2009

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

University of Arizona

University of Arizona Cancer Center

Cleveland Clinic

Claudia M. Espitia is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, pharmacology, and molecular oncology.

ORCID

Publications per year

2009–2022

23

Publications

23

Combined autophagy and HDAC inhibition

Devalingam Mahalingam, Monica Mita, John Sarantopoulos et al. · Autophagy · 2014 · 289 citations · Full text

, , +17

Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis

Jennifer S. Carew, Claudia M. Espitia, Juan Esquivel et al. · Journal of Biological Chemistry · 2010 · 152 citations · Full text

, , +17

Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels

Devalingam Mahalingam, Ernest Medina, Juan Esquivel et al. · Clinical Cancer Research · 2009 · 119 citations

, , +17

Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer

Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith et al. · Clinical Cancer Research · 2013 · 117 citations

, , +15

Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma

Kevin R. Kelly, Claudia M. Espitia, Devalingam Mahalingam et al. · Oncogene · 2011 · 80 citations

, , +17

1–5 of 23